United Therapeutics Shares Outstanding 2006-2020 | UTHR

United Therapeutics shares outstanding history from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • United Therapeutics shares outstanding for the quarter ending December 31, 2020 were 0.045B, a 1.83% increase year-over-year.
  • United Therapeutics 2020 shares outstanding were 0.045B, a 1.83% increase from 2019.
  • United Therapeutics 2019 shares outstanding were 0.044B, a 0.45% decline from 2018.
  • United Therapeutics 2018 shares outstanding were 0.044B, a 2% decline from 2017.
United Therapeutics Annual Shares Outstanding
(Millions of Shares)
2020 45
2019 44
2018 44
2017 45
2016 47
2015 51
2014 54
2013 53
2012 53
2011 59
2010 60
2009 56
2008 46
2007 45
2006 48
2005 50
United Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2020-12-31 45
2020-09-30 45
2020-06-30 44
2020-03-31 44
2019-12-31 44
2019-09-30 44
2019-06-30 44
2019-03-31 44
2018-12-31 44
2018-09-30 44
2018-06-30 43
2018-03-31 44
2017-12-31 45
2017-09-30 44
2017-06-30 45
2017-03-31 46
2016-12-31 47
2016-09-30 46
2016-06-30 47
2016-03-31 49
2015-12-31 51
2015-09-30 50
2015-06-30 52
2015-03-31 47
2014-12-31 54
2014-09-30 47
2014-06-30 53
2014-03-31 57
2013-12-31 53
2013-09-30 54
2013-06-30 53
2013-03-31 52
2012-12-31 53
2012-09-30 54
2012-06-30 54
2012-03-31 55
2011-12-31 59
2011-09-30 61
2011-06-30 63
2011-03-31 63
2010-12-31 60
2010-09-30 60
2010-06-30 60
2010-03-31 60
2009-12-31 56
2009-09-30 58
2009-06-30 53
2009-03-31 54
2008-12-31 46
2008-09-30 51
2008-06-30 49
2008-03-31 48
2007-12-31 45
2007-09-30 45
2007-06-30 44
2007-03-31 43
2006-12-31 48
2006-09-30 50
2006-06-30 51
2006-03-31 51
2005-12-31 50
2005-09-30 51
2005-06-30 50
2005-03-31 49
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $9.075B $1.483B
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.622B 43.54
Takeda Pharmaceutical (TAK) Japan $53.899B 9.87
Astellas Pharma (ALPMY) Japan $28.188B 17.40
Eisai (ESALY) Japan $19.828B 21.99
Catalent (CTLT) United States $18.827B 49.82
Grifols, S.A (GRFS) Spain $12.362B 14.38
Jazz Pharmaceuticals (JAZZ) Ireland $9.513B 15.89
Neurocrine Biosciences (NBIX) United States $9.130B 21.04
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.997B 0.00
IPSEN SA ADR (IPSEY) France $7.765B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $7.022B 0.00
Evotec AG (EVTCY) Germany $6.594B 445.28
Orion OYJ (ORINY) Finland $5.789B 0.00
Ionis Pharmaceuticals (IONS) United States $5.744B 0.00
Sage Therapeutics (SAGE) United States $4.358B 0.00
Hypermarcas (HYPMY) Brazil $3.972B 15.68
Turning Point Therapeutics (TPTX) United States $3.577B 0.00
Nektar Therapeutics (NKTR) United States $3.464B 0.00
PTC Therapeutics (PTCT) United States $3.417B 0.00
ChemoCentryx (CCXI) United States $3.246B 0.00
Cronos Group (CRON) Canada $3.012B 0.00
Revolution Medicines (RVMD) United States $2.959B 0.00
Tilray (TLRY) Canada $2.954B 0.00
Relay Therapeutics (RLAY) United States $2.947B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.894B 17.92
Pacira BioSciences (PCRX) United States $2.766B 46.72
Organogenesis Holdings (ORGO) United States $2.747B 165.08
Corcept Therapeutics (CORT) United States $2.671B 26.78
Xencor (XNCR) United States $2.449B 0.00
USANA Health Sciences (USNA) United States $2.039B 16.88
BioCryst Pharmaceuticals (BCRX) United States $1.997B 0.00
FibroGen (FGEN) United States $1.833B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.766B 11.33
Ironwood Pharmaceuticals (IRWD) United States $1.708B 13.43
Heron Therapeutics (HRTX) United States $1.633B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.574B 0.00
ImmunoGen (IMGN) United States $1.502B 0.00
Endo (ENDP) Ireland $1.443B 2.18
AlloVir (ALVR) United States $1.438B 0.00
Translate Bio (TBIO) United States $1.417B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.416B 0.00
Sundial Growers (SNDL) Canada $1.406B 0.00
Aclaris Therapeutics (ACRS) United States $1.382B 0.00
Indivior (INVVY) United States $1.363B 0.00
Ocular Therapeutix (OCUL) United States $1.209B 0.00
Zogenix (ZGNX) United States $1.060B 0.00
Trillium Therapeutics (TRIL) Canada $1.028B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.022B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Radius Health (RDUS) United States $0.924B 0.00
4D Molecular Therapeutics (FDMT) $0.886B 0.00
Vectura Group (VEGPF) United Kingdom $0.864B 0.00
Ardelyx (ARDX) United States $0.858B 0.00
Bioventus (BVS) United States $0.842B 0.00
Collegium Pharmaceutical (COLL) United States $0.819B 30.62
Aerie Pharmaceuticals (AERI) United States $0.809B 0.00
Esperion Therapeutics (ESPR) United States $0.761B 0.00
Karyopharm Therapeutics (KPTI) United States $0.729B 0.00
Silence Therapeutics (SLN) United Kingdom $0.689B 0.00
Chinook Therapeutics (KDNY) United States $0.674B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.671B 0.00
Rafael Holdings (RFL) United States $0.657B 0.00
Harpoon Therapeutics (HARP) United States $0.648B 0.00
VAXART, INC (VXRT) United States $0.630B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.609B 0.00
KalVista Pharmaceuticals (KALV) United States $0.594B 0.00
Nanobiotix S.A (NBTX) France $0.570B 0.00
Siga Technologies (SIGA) United States $0.557B 9.31
Crinetics Pharmaceuticals (CRNX) United States $0.553B 0.00
Sigilon Therapeutics (SGTX) $0.537B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.517B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.504B 0.00
Flexion Therapeutics (FLXN) United States $0.470B 0.00
TherapeuticsMD (TXMD) United States $0.466B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.461B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.461B 10.83
Altimmune (ALT) United States $0.456B 0.00
Molecular Templates (MTEM) United States $0.455B 0.00
Akebia Therapeutics (AKBA) United States $0.454B 0.00
AVITA Medical (RCEL) United States $0.447B 0.00
Summit Therapeutics (SMMT) United States $0.444B 0.00
Foghorn Therapeutics (FHTX) United States $0.423B 0.00
Jounce Therapeutics (JNCE) United States $0.413B 0.00
PROFOUND MEDICL (PROF) Canada $0.409B 0.00
Nature's Sunshine Products (NATR) United States $0.400B 19.08
DURECT (DRRX) United States $0.389B 0.00
MEI Pharma (MEIP) United States $0.380B 0.00
Acutus Medical (AFIB) United States $0.362B 0.00
Innate Pharma SA (IPHYF) France $0.352B 0.00
Redhill Biopharma (RDHL) Israel $0.329B 0.00
Oncternal Therapeutics (ONCT) United States $0.320B 0.00
Clever Leaves Holdings (CLVR) United States $0.276B 0.00
VYNE Therapeutics (VYNE) United States $0.274B 0.00
Infinity Pharmaceuticals (INFI) United States $0.264B 0.00
Alpine Immune Sciences (ALPN) United States $0.263B 0.00
Taiwan Liposome (TLC) Taiwan $0.252B 0.00
Inotiv (NOTV) United States $0.250B 0.00
CASI Pharmaceuticals (CASI) United States $0.250B 0.00
KemPharm (KMPH) United States $0.244B 0.00
Xeris Pharmaceuticals (XERS) United States $0.234B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.231B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.215B 0.00
4D Pharma (LBPS) United Kingdom $0.213B 0.00
Sierra Oncology (SRRA) Canada $0.209B 0.00
Progenity (PROG) United States $0.203B 0.00
Lannett Co Inc (LCI) United States $0.197B 6.61
Iterum Therapeutics (ITRM) Ireland $0.194B 0.00
CTI BioPharma (CTIC) United States $0.189B 0.00
IMV INC (IMV) Canada $0.187B 0.00
OptiNose (OPTN) United States $0.186B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.179B 0.00
Jaguar Animal Health (JAGX) United States $0.169B 0.00
Novan (NOVN) United States $0.167B 0.00
Heat Biologics (HTBX) United States $0.164B 0.00
Gain Therapeutics (GANX) United States $0.164B 0.00
Adherex Technologies (FENC) United States $0.163B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.163B 0.00
SCYNEXIS (SCYX) United States $0.159B 0.00
Calithera Biosciences (CALA) United States $0.158B 0.00
Vivos Therapeutics (VVOS) $0.152B 0.00
Qilian Holding Group (QLI) China $0.149B 0.00
Champions Oncology (CSBR) United States $0.148B 0.00
Aquestive Therapeutics (AQST) United States $0.147B 0.00
Onconova Therapeutics (ONTX) United States $0.143B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.143B 0.00
Concert Pharmaceuticals (CNCE) United States $0.142B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.138B 0.00
MediWound (MDWD) Israel $0.137B 0.00
GlycoMimetics (GLYC) United States $0.135B 0.00
Nutriband (NTRB) United States $0.133B 0.00
Aziyo Biologics (AZYO) United States $0.132B 0.00
Lipocine (LPCN) United States $0.129B 0.00
Genocea Biosciences (GNCA) United States $0.118B 0.00
Natural Alternatives (NAII) United States $0.116B 31.38
La Jolla Pharmaceutical (LJPC) United States $0.112B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.109B 0.00
Minerva Neurosciences (NERV) United States $0.109B 42.33
Otonomy (OTIC) United States $0.107B 0.00
PolarityTE (PTE) United States $0.106B 0.00
Savara (SVRA) United States $0.095B 0.00
Regulus Therapeutics (RGLS) United States $0.094B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.090B 0.00
ElectroCore (ECOR) United States $0.087B 0.00
Recro Pharma (REPH) United States $0.086B 0.00
Assertio Holdings (ASRT) United States $0.084B 0.00
ProPhase Labs (PRPH) United States $0.081B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.077B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.075B 0.00
Baudax Bio (BXRX) United States $0.075B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.071B 0.00
Sigyn Therapeutics (SIGY) United States $0.068B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Biomerica (BMRA) United States $0.058B 0.00
Brickell Biotech (BBI) United States $0.057B 0.00
IntelGenx Technologies (IGXT) Canada $0.054B 0.00
Inhibikase Therapeutics (IKT) United States $0.053B 0.00
HANCOCK JAFFE (HJLI) United States $0.052B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.051B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 59.80
Viracta Therapeutics (VIRX) United States $0.041B 0.00
Mannatech (MTEX) United States $0.040B 7.03
RXi Pharmaceuticals (PHIO) United States $0.031B 0.00
Petros Pharmaceuticals (PTPI) United States $0.031B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.031B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.027B 0.00
Midatech Pharma (MTP) United Kingdom $0.024B 0.00
JanOne (JAN) United States $0.021B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
Plus Therapeutics (PSTV) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 15.70
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
SHINECO INC (TYHT) China $0.018B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00